Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.900 | strong | 0.915 | 1 | 0 | 1998 | 2020 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.986 | 2 | 0 | 2000 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
ADAM metallopeptidase domain 9 | 0.560 | 0.654 | 2.9E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2014 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 1 | 0 | 1999 | 2019 | ||||||||
|
amyloid beta precursor like protein 2 | 0.659 | 0.462 | 0.38 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 1994 | 2012 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.946 | 2 | 0 | 1991 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.900 | None | 0.981 | 3 | 0 | 1987 | 2020 | ||||||||
|
ATP synthase F1 subunit alpha | 0.604 | 0.731 | 1.00 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2015 | ||||||||
|
beta-secretase 1 | 0.559 | 0.769 | 0.88 |
|
disease | 0.600 | None | 0.985 | 1 | 0 | 1999 | 2020 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.520 | None | 1.000 | 5 | 0 | 1997 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1996 | 2019 | ||||||||
|
BCL2 like 2 | 0.599 | 0.615 | 0.47 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2010 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 0.958 | 2 | 0 | 1991 | 2020 | ||||||||
|
caspase 12 (gene/pseudogene) | 0.638 | 0.808 | 1.3E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.600 | None | 0.980 | 3 | 0 | 1999 | 2020 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.290 | None | 1.000 | 0 | 0 | 2004 | 2020 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 2004 | 2019 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 1987 | 2019 | ||||||||
|
calcium and integrin binding 1 | 0.458 | 0.769 | 3.3E-04 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 1998 | 2019 |